Recently you received a lot information related to Brexit. The key question in that regard: what is the next most favorable step for your Pharma and Life Sciences business? The center of the discussion should still be the handling of your supply chain.
Please find hereinafter some inputs in that regard from an UK, Ireland and Swiss perspective for your convenience:
In case of any questions, please do not hesitate to contact our local champions and/or me.
Kind regards Sandra